NANOG and esophageal squamous cell carcinoma: The mRNA and protein expression of SOX9, SOX2, OCT4, and NANOG notably reduced with RNAPII inhibition in these ESCC cells (Fig. 1c, d), suggesting that stemness-related genes expression was sensitive to THZ1 therapy.